Leukemia & Lymphoma, Volume 62, Issue 3 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 62, Issue 3 (2021)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Volume 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentries

Article Commentary
“RT or not RT?” The question for early-stage peripheral T-cell lymphoma
Belinda A. Campbell & Amit Khot
Pages: 511-513
Published online: 29 Jan 2021
First Page Previewfor“RT or not RT?” The question for early-stage peripheral T-cell lymphoma | Full Text | References | PDF (300 KB) | EPUB
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Metabolism meets apoptosis in AML
Natalia Timofeeva & Varsha Gandhi
Pages: 514-516
Published online: 25 Dec 2020
First Page PreviewforMetabolism meets apoptosis in AML | Full Text | References | PDF (726.9 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

The role of PI3K inhibitors in the treatment of malignant lymphomas
Philipp Berning & Georg Lenz
Pages: 517-527
Published online: 02 Nov 2020
AbstractforThe role of PI3K inhibitors in the treatment of malignant lymphomas | Full Text | References | PDF (1.3 MB) | EPUB
  • 335 Views
  • 5 CrossRef citations
  • 0Altmetric
Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms
Natalie Cheng Chen, Gautam Borthakur & Naveen Pemmaraju
Pages: 528-537
Published online: 08 Nov 2020
AbstractforBromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms | Full Text | References | PDF (932.1 KB) | EPUB
  • 300 Views
  • 15 CrossRef citations
  • 0Altmetric

Original Articles

Article
Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?
Joshua L. Rodríguez-López, Ankur K. Patel, Goundappa K. Balasubramani, Scott M. Glaser, Sushil Beriwal & John A. Vargo
Pages: 538-548
Published online: 30 Nov 2020
AbstractforTreatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy? | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 216 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands
Djamila E. Issa, Avinash G. Dinmohamed, Marielle J. Wondergem, Hedwig M. Blommestein, Peter C. Huijgens, Pieternella J. Lugtenburg, Otto Visser, Sonja Zweegman & Martine E. D. Chamuleau
Pages: 549-559
Published online: 19 Nov 2020
AbstractforA population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 305 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care
Maria Christina Cox, Sveva Maria Nusca, Francesca Di Landro, Gabriella Marsilli, Giulia Stella, Matilde Sigona, Federica Ponzelli, Jasmine Passerini Desideri, Francesca Di Gregorio, Flavia Santoboni, Mario Vetrano, Donatella Trischitta, Renato Manno & Maria Chiara Vulpiani
Pages: 560-570
Published online: 24 Nov 2020
AbstractforExercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 359 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
Mei-ting Chen, Xiao-hong Fu, He Huang, Zhao Wang, Xiao-jie Fang, Yu-Yi Yao, Quan-Guang Ren, Ze-geng Chen & Tong-yu Lin
Pages: 571-580
Published online: 06 Nov 2020
AbstractforCombination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) | Full Text | References | PDF (1.2 MB) | EPUB
  • 339 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Racial and ethnic differences in diffuse large B-cell lymphoma survival among an underserved, urban population
Deanna Blansky, Melissa Fazzari, Ioannis Mantzaris, Thomas Rohan & H. Dean Hosgood
Pages: 581-589
Published online: 28 Oct 2020
AbstractforRacial and ethnic differences in diffuse large B-cell lymphoma survival among an underserved, urban population | Full Text | References | PDF (867.6 KB) | EPUB | Supplemental
  • 248 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew Chapman, Matthew Carabasi, Martina DiMeglio, Jerald Gong, Ubaldo Martinez-Outschoorn, Lewis Rose, Michael Ramirez, John L. Wagner, Mark Weiss, Neal Flomenberg, Barbara Pro, Pierluigi Porcu, Joanne Filicko-OHara & Sameh Gaballa
Pages: 590-597
Published online: 04 Nov 2020
AbstractforPhase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma | Full Text | References | PDF (814.2 KB) | EPUB
  • 261 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma
Thomas D. Rodgers, AnnaLynn M. Williams, Andrea Baran, Patrick M. Reagan, Carla Casulo, Clive S. Zent, Andrew Evans, Jonathan W. Friedberg & Paul M. Barr
Pages: 598-605
Published online: 25 Oct 2020
AbstractforToxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 265 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma
Scott Moerdler, Michelle Ewart, Debra L. Friedman, Kara Kelly, Qinglin Pei, Mou Peng, XingXing Zang & Peter D. Cole
Pages: 606-613
Published online: 28 Oct 2020
AbstractforLAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma | Full Text | References | PDF (1.3 MB) | EPUB
  • 295 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman’s disease
Kazutoshi Ebisawa, Arika Shimura, Akira Honda, Yosuke Masamoto, Fumio Nakahara & Mineo Kurokawa
Pages: 614-619
Published online: 19 Oct 2020
AbstractforHemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman’s disease | Full Text | References | PDF (705.3 KB) | EPUB
  • 175 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Marie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, Françoise Huguet, Céline Berthon, Célestine Simand, Maria-Pilar Gallego-Hernanz, Yosr Hicheri, Mathilde Hunault Berger, Colombe Saillard, Thibaut Leguay, Clémence Loiseau, Marie-Christine Béné & Patrice Chevallier
Pages: 620-629
Published online: 06 Nov 2020
AbstractforBlinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults | Full Text | References | PDF (783 KB) | EPUB
  • 1951 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis
Gabriel Buschner, Benedikt Feuerecker, Sabine Spinner, Christof Seidl & Markus Essler
Pages: 630-639
Published online: 03 Nov 2020
AbstractforDifferentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis | Full Text | References | PDF (1.3 MB) | EPUB
  • 200 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Variables associated with self-reported anxiety and depression symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy
Dayu Shi, Zongru Li, Yongjie Li & Qian Jiang
Pages: 640-648
Published online: 05 Nov 2020
AbstractforVariables associated with self-reported anxiety and depression symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy | Full Text | References | PDF (962.5 KB) | EPUB
  • 349 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Tyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient views
Vashti N. M. F. Tromp, Lonneke Timmers, Leanne Koningen, Jeroen J. W. M. Janssen, Peter E. Westerweel, Inge G. P. Geelen, Jan de Jong, Jan J. Beckeringh, Christel C. L. M. Boons & Jacqueline G. Hugtenburg
Pages: 649-658
Published online: 06 Nov 2020
AbstractforTyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient views | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2030 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, María José Herrero, Rebeca Rodríguez-Veiga, Antonio Solana-Altabella, Blanca Boluda, Octavio Ballesta-López, Isabel Cano, Evelyn Acuña-Cruz, José Cervera, José Luis Poveda, MiguelÁngel Sanz, Salvador F. Aliño & Pau Montesinos
Pages: 659-668
Published online: 02 Nov 2020
AbstractforImpact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 276 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia
Fabio Efficace, Alessandra Iurlo, Andrea Patriarca, Fabio Stagno, Ping-Chong Bee, Geneviève Ector, Isabella Capodanno, Chiara Elena, Massimiliano Bonifacio, Nicole M. A. Blijlevens, Giovanni Caocci, Chonghua Wan, Elisabetta Abruzzese, Massimo Breccia, Francesco Cottone, Iris Okumura, Simone Oerlemans, Nicola Cascavilla, Francesco Albano, Vamsi Kota, Monika Sztankay, Maria Cristina Miggiano, Susanne Saussele, Nicola Di Renzo, Federica Sorà, Fausto Castagnetti, Michele Baccarani, Marco Vignetti & Gianantonio Rosti
Pages: 669-678
Published online: 06 Nov 2020
AbstractforValidation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 570 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Detection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph+ B cells but not bone marrow stem/progenitors
Daiki Karigane, Hidenori Kasahara, Kouhei Shiroshita, Shinya Fujita, Hiroshi Kobayashi, Shinpei Tamaki, Rie Yamazaki, Kaori Yahagi, Yoko Yatabe, Naomi Kondoh, Tomoko Arai, Hisako Katagiri, Nobuko Shimizu, Masatoshi Sakurai, Taku Kikuchi, Jun Kato, Takayuki Shimizu, Taeko Hayakawa, Tomonori Yaguchi, Maiko Matsushita, Hideaki Nakajima, Yutaka Kawakami, Mitsuru Murata, Takehiko Mori, Takashi Sasaki, Shinichiro Okamoto & Keiyo Takubo
Pages: 679-687
Published online: 26 Oct 2020
AbstractforDetection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph+ B cells but not bone marrow stem/progenitors | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 233 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Congenital acute myeloid leukemia: challenges and lessons. A 15-year experience from the UK
Katherine Green, Sneha Tandon, Mansur Ahmed, Wanda Toscano, David O’Connor, Philip Ancliff, Ajay Vora, Jack Bartram, Sujith Samarasinghe, Sara Ghorashian, Vesna Pavasovic & Anupama Rao
Pages: 688-695
Published online: 23 Nov 2020
AbstractforCongenital acute myeloid leukemia: challenges and lessons. A 15-year experience from the UK | Full Text | References | PDF (721.4 KB) | EPUB
  • 548 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia
Craig W. Freyer, Chelsea E. Peterson, Yun Man, Amanda Przespolewski, Jeffrey Baron & Selina M. Luger
Pages: 696-702
Published online: 26 Oct 2020
AbstractforHerpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia | Full Text | References | PDF (771.6 KB) | EPUB
  • 275 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Evaluation of the efficacy and safety of arsenic trioxide dosing in obese patients with acute promyelocytic leukemia
Barbara Barsoum, Amrita Henneman, Samrah Ahmad & Cristina Ghiuzeli
Pages: 703-708
Published online: 27 Oct 2020
AbstractforEvaluation of the efficacy and safety of arsenic trioxide dosing in obese patients with acute promyelocytic leukemia | Full Text | References | PDF (489.1 KB) | EPUB
  • 339 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment
Qinglin Shi, Chao Wu, Wenmin Han, Sishu Zhao, Yujie Wu, Yuanyuan Jin, Xiaoyan Qu, Jianyong Li, Run Zhang & Lijuan Chen
Pages: 709-715
Published online: 27 Oct 2020
AbstractforClinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment | Full Text | References | PDF (749.4 KB) | EPUB
  • 209 Views
  • 1 CrossRef citations
  • 0Altmetric

Letters to the Editor

Article
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
Soun Khountham, Polina Shindiapina, Xiaokui Mo, Curtis Lachowiez, Tracy Wiczer, Luay Mousa, Kerry A. Rogers, Leslie A. Andritsos, Jennifer A. Woyach, John C. Byrd, Stephen E. Spurgeon & Farrukh T. Awan
Pages: 716-721
Published online: 19 Nov 2020
First Page PreviewforNatural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia | Full Text | References | PDF (1 MB) | EPUB
  • 336 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Curative surgery in highly selected patients with heavily pretreated, relapsed/refractory classical Hodgkin lymphoma
Vassilios Papadakis, Maria Efstathopoulou, Maria K. Angelopoulou, Gerassimos Tsourouflis, Vassilios Prassopoulos, Phivi Rondogianni, Antonios Kourtesis, Sophia Polychronopoulou, Gerassimos A. Pangalis & Theodoros P. Vassilakopoulos
Pages: 722-726
Published online: 25 Nov 2020
First Page PreviewforCurative surgery in highly selected patients with heavily pretreated, relapsed/refractory classical Hodgkin lymphoma | Full Text | References | PDF (837.1 KB) | EPUB
  • 128 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Treatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma
Brandon M. Lehrich, Khodayar Goshtasbi, Arash Abiri, Tyler M. Yasaka, Peter Papagiannopoulos, Bobby A. Tajudeen, Elizabeth A. Brem & Edward C. Kuan
Pages: 727-730
Published online: 15 Oct 2020
First Page PreviewforTreatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 161 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China
Chunyan Sun, Junying Li, Hang Xiang, Chunrui Li, Anfang Shang, Wei Chang, Xiya Gui, Yadan Wang, Hongxiang Wang, Qianwen Cheng, Chun Zhang, Guolin Yuan, Chucheng Wan, Qihuan Liu, Long Wang, Zhiping Huang, Caixia Liang, Yaogong Wu & Yu Hu
Pages: 731-734
Published online: 03 Dec 2020
First Page PreviewforCOVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China | Full Text | References | PDF (499.4 KB) | EPUB
  • 1235 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia
Vera Adema, Jack Khouri, Ying Ni, Heesun J. Rogers, Cassandra M. Kerr, Hassan Awada, Yasunobu Nagata, Teodora Kuzmanovic, Anjali S. Advani, Aaron T. Gerds, Sudipto Mukherjee, Aziz Nazha, Yogen Saunthararajah, Yazan Madanat, Bhumika J. Patel, Francesc Solé, Steffan T. Nawrocki, Jennifer S. Carew, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Valeria Visconte & Hetty E. Carraway
Pages: 735-738
Published online: 03 Nov 2020
First Page PreviewforAnalysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 346 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study
Oliver G. Ottmann, Frank Stegelmann, Massimo Breccia, Juan Luis Steegmann, Eduardo Olavarria, Paola Aimone & Jeffrey H. Lipton
Pages: 739-742
Published online: 06 Nov 2020
First Page PreviewforSmoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study | Full Text | References | PDF (578.7 KB) | EPUB
  • 152 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Azacitidine is removed effectively by hemodialysis
A. G. E Beer, E. Laille, H. Neuwirt, G. Mayer & R. Stauder
Pages: 743-745
Published online: 25 Oct 2020
First Page PreviewforAzacitidine is removed effectively by hemodialysis | Full Text | References | PDF (490.1 KB) | EPUB
  • 506 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Imatinib, cheese and migraines
Michael Woodfin, Laura Bickel & Michael Deininger
Pages: 746-748
Published online: 28 Oct 2020
First Page PreviewforImatinib, cheese and migraines | Full Text | References | PDF (405.2 KB) | EPUB
  • 239 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?
Ramzi Abboud, Michael Slade, Camille Abboud & John F. DiPersio
Pages: 749-751
Published online: 02 Nov 2020
First Page PreviewforCan planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation? | Full Text | References | PDF (480.1 KB) | EPUB
  • 269 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment
Barbora Vakrmanova, Eva Fronkova, Jan Zuna, Iveta Janotova, Yahia Jabali, Leona Rezkova Reznickova, Katerina Zdrahalova, Jan Trka, Jan Stary, Ondrej Hrusak & Ester Mejstrikova
Pages: 752-754
Published online: 29 Oct 2020
First Page PreviewforBlast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment | Full Text | References | PDF (555 KB) | EPUB
  • 130 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia
Monia Lunghi, Andrea Patriarca, Mariangela Greco, Akram Taherinasab, Irene Della Starza, Marzia Cavalli, Gianluca Gaidano, Robin Foà, Sabina Chiaretti & on behalf of the Campus ALL
Pages: 755-757
Published online: 05 Nov 2020
First Page PreviewforPonatinib for the treatment of Ph-like acute lymphoblastic leukemia | Full Text | References | PDF (709.1 KB) | EPUB
  • 352 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Maintenance regimens after a second autologous transplant for multiple myeloma
Ghulam Rehman Mohyuddin, Maire Okoniewski, Osama Diab, Siddhartha Ganguly, Leyla Shune, Al-Ola Abdallah, Joseph McGuirk & Brian McClune
Pages: 758-760
Published online: 04 Nov 2020
First Page PreviewforMaintenance regimens after a second autologous transplant for multiple myeloma | Full Text | References | PDF (352.4 KB) | EPUB | Supplemental
  • 179 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Screening for Gaucher disease among patients with plasma cell dyscrasias
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos & Evangelos Terpos
Pages: 761-763
Published online: 30 Sep 2019
First Page PreviewforScreening for Gaucher disease among patients with plasma cell dyscrasias | Full Text | References | PDF (828.4 KB) | EPUB
  • 193 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia
Kapil S. Meleveedu, Dong Chen, Kalyan Nadiminti, Hasib Sidiqi, Shakila Khan, Hassan Alkhateeb, Mithun V. Shah, Mrinal Patnaik, William J. Hogan, Kebede Begna & Mark Litzow
Pages: 764-767
Published online: 12 Oct 2019
First Page PreviewforPD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia | Full Text | References | PDF (1 MB) | EPUB
  • 276 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases
Guopan Yu et al.
Article | Published online: 13 Jun 2024
Impact of chronic graft-versus-host disease on non-relapse mortality and survival
Justin Jiang et al.
Article | Published online: 12 Jun 2024
Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what’s next?
Teena Bhatla et al.
Review Article | Published online: 11 Jun 2024
View all latest articles